EP Patent

EP3293196A1 — Process for purifying obeticholic acid

Assigned to Hexal AG · Expires 2018-03-14 · 8y expired

What this patent protects

The invention relates to a process for purifying obeticholic acid. In addition, crystalline forms of obeticholic acid are provided which are useful synthetic intermediates for the production of highly pure amorphous obeticholic acid. Accordingly, the invention also relates to a p…

USPTO Abstract

The invention relates to a process for purifying obeticholic acid. In addition, crystalline forms of obeticholic acid are provided which are useful synthetic intermediates for the production of highly pure amorphous obeticholic acid. Accordingly, the invention also relates to a process for preparing amorphous obeticholic acid.

Drugs covered by this patent

Patent Metadata

Patent number
EP3293196A1
Jurisdiction
EP
Classification
—
Expires
2018-03-14
Drug substance claim
No
Drug product claim
No
Assignee
Hexal AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.